| Name |
Administration |
Indication |
| Halaven® (eribulin mesylate) |
non-SAI |
Metastatic breast cancer |
| Helixate® FS
(antihemophilic factor [recombinant]) |
non-SAI |
Hemophilia |
| Hemofil® M (antihemophilic factor [human]) |
non-SAI |
Hemophilia |
| Herceptin® (trastuzumab) |
non-SAI |
Cancer |
| H.P. Acthar® Gel (corticotropin) |
SAI |
Various indications |
| Hizentra® (immune globulin, gamma) |
non-SAI |
Immune Deficiency |
| Humate-P® (antihemophilic factor/von Willebrand
factor complex [human]) |
non-SAI |
Hemophilia |
| Humatrope® (somatropin [rDNA origin]) |
SAI |
Growth Stimulant |
| Humira® (adalimumab) |
SAI |
Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis,
Psoriasis, Crohn's Disease |
| Hyalgan ® (sodium hyaluronate) |
non-SAI |
Osteoarthritis |
| Hycamtin® capsules (topotecan) |
oral |
Cancer |
| HyperRho® S/D (Rho[D] immune globulin [human]) |
non-SAI |
Rh isoimmunization |